Aqueous humour interleukin-6 and vision outcomes with anti-vascular endothelial growth factor therapy.

Yasir Jamal SepahDiana V DoMarina MesquidaBann-Mo DaySteven BlotnerRubbia AfridiMuhammad Sohail HalimKyu HongEric WakshullSascha FauserIvaylo StoilovQuan Dong Nguyennull nullnull null

Published in: Eye (London, England) (2024)

Higher IL-6 AH concentrations may predict suboptimal visual responses to anti-VEGF monotherapy in patients with nAMD/DMO.

Keyphrases

vascular endothelial growth factor
endothelial cells
open label
randomized controlled trial
stem cells
type diabetes
clinical trial
metabolic syndrome
insulin resistance
study protocol
smoking cessation